Cargando…

Next generation sequencing predicting clinical effect of immunotherapy on adult rhabdomyosarcoma patient: A case report

Rhabdomyosarcoma (RMS) is a rare sarcoma that rarely occurs in adults and accounts for only 1% of all adult tumors. The standard treatment for RMS is surgical resection, radiotherapy, and chemotherapy. PATIENT CONCERNS: Adult patients often present with an aggressive course and poor prognosis. DIAGN...

Descripción completa

Detalles Bibliográficos
Autores principales:	Sun, Xiaogang, Wang, Xinyu, Zhou, Jun, Xu, Yali, Zhang, Hao, Xu, Mian, Shen, Jiaojiao, Shi, Xiaoliang, Song, Wei, Li, Jun
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Lippincott Williams & Wilkins 2023
Materias:	5700
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10219687/ https://www.ncbi.nlm.nih.gov/pubmed/37233406 http://dx.doi.org/10.1097/MD.0000000000033858

Ejemplares similares

An uncommon perineal embryonal rhabdomyosarcoma in adult: A case report
por: Qu, Sifeng, et al.
Publicado: (2022)

Perianal rhabdomyosarcoma in an adult: A case report and review of the literature
por: Yang, Ning, et al.
Publicado: (2023)

Clinical application of next-generation sequencing for the management of desmoid tumors: A case report and literature review
por: Lee, Jeong Mi, et al.
Publicado: (2021)

MYL2 as a potential predictive biomarker for rhabdomyosarcoma
por: Wang, Junning, et al.
Publicado: (2021)

Targeted next-generation sequencing of malignant peripheral nerve sheath tumor of the pterygopalatine fossa with intracranial metastatic recurrence
por: Bao, Xinjie, et al.
Publicado: (2018)

Single-cell transcriptional profiling reveals the heterogeneity in embryonal rhabdomyosarcoma
por: Hong, Bo, et al.
Publicado: (2021)

Next-generation sequencing in thyroid cancers: do targetable alterations lead to a therapeutic advantage?: A multicenter experience
por: Moore, Assaf, et al.
Publicado: (2021)

Survival and prognostic analysis of preoperative indicators in patients undergoing surgical resections with rhabdomyosarcoma
por: Jin, Hongyu, et al.
Publicado: (2020)

Immune-related risk prognostic model for clear cell renal cell carcinoma: Implications for immunotherapy
por: Chen, Ronghui, et al.
Publicado: (2023)

Primary Renal Rhabdomyosarcoma in an Adolescent With Tumor Thrombosis in the Inferior Vena Cava and Right Atrium: A Case Report and Review of the Literature
por: Lin, Wei-Ching, et al.
Publicado: (2016)

Construction of an m6A-related lncRNA model for predicting prognosis and immunotherapy in patients with lung adenocarcinoma
por: Shen, Hong-Yu, et al.
Publicado: (2023)

CD56–chimeric antigen receptor T-cell therapy for refractory/recurrent rhabdomyosarcoma: A 3.5-year follow-up case report
por: Jiang, Chiyi, et al.
Publicado: (2019)

Phase II study of vincristine, actinomycin-D, cyclophosphamide and irinotecan for patients with newly diagnosed low-risk subset B rhabdomyosarcoma: A study protocol
por: Miyachi, Mitsuru, et al.
Publicado: (2019)

Iodine-125 radioactive particles antagonize hyperprogressive disease following immunotherapy: A case report
por: Yang, Ning, et al.
Publicado: (2020)

Clinical characteristics and survival outcomes of patients with both primary breast cancer and primary ovarian cancer
por: Chen, Chang, et al.
Publicado: (2020)

Construction of a pyroptosis-related lncRNAs signature for predicting prognosis and immunotherapy response in glioma
por: Huang, Qianrong, et al.
Publicado: (2023)

The safety and efficacy of chemotherapy combined with immunotherapy for pancreatic cancer: A meta-analysis
por: Huang, Yang, et al.
Publicado: (2021)

Bibliometric and visualized analysis of the top-100 highly cited articles on immunotherapy for endometrial cancer
por: Zheng, Wanzhen, et al.
Publicado: (2023)

Comprehensive characterization of MUC16 mutations in lung adenocarcinoma for immunotherapies and prognosis: An observational study
por: Liu, Tingjun, et al.
Publicado: (2023)

A prognostic signature associated with cell senescence predicts survival outcomes and strongly associates with immunotherapy and chemotherapy response in breast cancer
por: Pan, Tao, et al.
Publicado: (2023)

Identification of a novel cell cycle-related risk signature predicting prognosis in patients with pancreatic adenocarcinoma
por: Xu, Dapeng, et al.
Publicado: (2022)

Cuproptosis-related prognostic signatures predict the prognosis and immunotherapy in HCC patients
por: Peng, Hong, et al.
Publicado: (2023)

Effect of indwelling depth of peripheral intravenous catheters on thrombophlebitis
por: He, Chenghong, et al.
Publicado: (2023)

Lung metastasis from thyroid cancer: A case report of unusual imaging presentation of lung metastases
por: Song, Wenjing, et al.
Publicado: (2023)

Chemotherapy efficacy after first-line immunotherapy in 18 advanced melanoma patients
por: Saint-Jean, Mélanie, et al.
Publicado: (2020)

Response to immunotherapy in a patient with anaplastic thyroid cancer: A case report
por: Zheng, Luming, et al.
Publicado: (2021)

Complete and long-lasting response to immunotherapy: A case report of urothelial cancer
por: Silva, Diogo J., et al.
Publicado: (2022)

Knowledge mapping of immunotherapy for thyroid cancer from 1980 to 2022: A review
por: Ding, Ran, et al.
Publicado: (2023)

Identification of cancer-associated fibroblasts signature for predicting the prognosis and immunotherapy response in hepatocellular carcinoma
por: Ye, Jianzhong, et al.
Publicado: (2023)

Short-term prognosis for hepatocellular carcinoma patients with lung metastasis: A retrospective cohort study based on the SEER database
por: Chen, Shicheng, et al.
Publicado: (2022)

Rare upper gastrointestinal hemorrhage of cetuximab: A case report
por: Duan, Shi-Jie, et al.
Publicado: (2017)

Efficacy and safety of anti-PD-1 and anti-PD-1 combined with anti-CTLA-4 immunotherapy to advanced melanoma: A systematic review and meta-analysis of randomized controlled trials
por: Hao, Chunyan, et al.
Publicado: (2017)

Primary adult primitive neuroectodermal tumor of the bladder: A case report and literature review
por: Liu, Bing, et al.
Publicado: (2020)

In vivo expansion and activation of γδ T cells as immunotherapy for refractory neuroblastoma: A phase 1 study
por: Pressey, Joseph G., et al.
Publicado: (2016)

Successful chemotherapy with continuous immunotherapy for primary pulmonary endovascular epithelioid hemangioendothelioma: A case report
por: Guo, Wenliang, et al.
Publicado: (2023)

Exploration of immune-related cells and ceRNA in squamous cell lung cancer
por: Wang, Lijun, et al.
Publicado: (2021)

The efficacy and safety of gemcitabine-based induction chemotherapy for locally advanced nasopharyngeal carcinoma treated with concurrent chemoradiation: A meta-analysis
por: Fei, Qian, et al.
Publicado: (2021)

CNN3 in glioma: The prognostic factor and a potential immunotherapeutic target
por: Xu, Hao, et al.
Publicado: (2021)

A prognostic and immunotherapy effectiveness model for pancreatic adenocarcinoma based on cuproptosis-related lncRNAs signature
por: Zhang, Ning, et al.
Publicado: (2023)

Prognostic value of immunoscore to identify mortality outcomes in adults with HBV-related primary hepatocellular carcinoma
por: Yao, Qinwei, et al.
Publicado: (2017)

Cannot write session to /tmp/vufind_sessions/sess_qtr6vgc97gleibacc64c7br08n